LIVER DISEASES
![Foto de LIVER DISEASES](/img/grupo.png)
![Foto de Universidade de Lisboa](/img/noimage_org.png)
Universidade de Lisboa
Lisboa, PortugalPublications in collaboration with researchers from Universidade de Lisboa (27)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
2023
-
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
JHEP Reports, Vol. 5, Núm. 5
-
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma
Molecular cancer therapeutics, Vol. 22, Núm. 3, pp. 343-356
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
miR-21-5p promotes NASH-related hepatocarcinogenesis
Liver International, Vol. 43, Núm. 10, pp. 2256-2274
2022
-
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190
2021
-
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
Frontiers in Medicine, Vol. 8
-
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
Cell Death and Disease, Vol. 12, Núm. 6
-
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)
British Journal of Cancer
-
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Gut, Vol. 70, Núm. 12, pp. 2359-2372
2020
-
A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
Cancers, Vol. 12, Núm. 6
-
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059
-
Diet-dependent gut microbiota impacts on adult neurogenesis through mitochondrial stress modulation
Brain Communications, Vol. 2, Núm. 2
-
Extracellular vesicles in non-alcoholic fatty liver disease: Key players in disease pathogenesis and promising biomarker tools
NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring (Springer International Publishing), pp. 157-180
2019
-
Diagnostic and prognostic biomarkers in cholangiocarcinoma
Liver International, Vol. 39, Núm. S1, pp. 108-122
-
Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis
Journal of Molecular Medicine, Vol. 97, Núm. 8, pp. 1113-1126
2018
-
MiRNA-21 ablation protects against liver injury and necroptosis in cholestasis
Cell Death and Differentiation, Vol. 25, Núm. 5, pp. 857-872
-
Modulation of liver steatosis by miR-21/PPARα
Cell Death Discovery
2017
-
MiR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
Cell Death and Disease, Vol. 8, Núm. 4
2016
-
Activation of necroptosis in human and experimental cholestasis
Cell Death and Disease, Vol. 7, Núm. 9